FTY720 promotes pulmonary fibrosis when administered during the remodelling phase following a bleomycin-induced lung injury
Keywords: Gilenya®; Bleomycin; Leakage; Inflammation; Sphingosine-1-phosphate; Fibrosis; ANOVA; Analysis of variance; BALF; bronchoalveolar lavage fluid; BSA; bovine serum albumin; CTGF; connective tissue growth factor; ELISA; enzyme-linked immunosorbent assay; Gn